Semaglutide: Decoding the hype around the weight loss wonder drug
From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becoming a $100 bn opportunity by 2030. While the drug’s innovator Novo Nordisk launched its oral version in India last year, Dr. Reddys Laboratories has now got approval to carry out bioequivalence studies of injectable semaglutide. So, what does this mean for India that has a huge disease burden of diabetes and obesity? Is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.